ASSOCIATION BETWEEN GENE ALTERATION AND DRUG-SENSITIVITY IN HUMAN LUNG-CARCINOMA CELL-LINES

被引：0
作者：
MIZUSHIMA, Y
KASHII, T
KOBAYASHI, M
机构：
来源：
ONCOLOGY REPORTS | 1995年 / 2卷 / 02期
关键词：
K-RAS; P53; N-MYC; LUNG CANCER; DRUG SENSITIVITY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The association between gene alterations (K-ras, p53, N-myc) and drug resistance (CDDP, CBDCA, MMC, Epi-ADM) was examined in 29 human lung carcinoma cell lines using the in vitro MTT assay. There was no significant difference in the IC50 values of four drugs between K-ras or p53 gene alteration-positive and -negative groups. However, two cell lines with N-myc amplification showed a higher resistance than those without N-myc amplification to all four drugs. This preliminary study suggests that K-ras or p53 gene alteration is probably not related to drug resistance, but N-myc might be.
引用
收藏
页码：277 / 280
页数：4
相关论文
共 50 条
[41]   Additive effect of TRAIL and p53 gene transfer on apoptosis of human lung cancer cell lines [J].
Jang, SH ;
Seol, JY ;
Kim, CH ;
Yoo, CG ;
Kim, YW ;
Ran, SK ;
Shim, YS ;
Lee, CT .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 13 (01) :181-186
[42]   GENE ANALYSIS OF K-RAS, H-RAS, P53, AND RETINOBLASTOMA SUSCEPTIBILITY GENES IN HUMAN LUNG-CANCER CELL-LINES BY THE POLYMERASE CHAIN-REACTION SINGLE-STRAND CONFORMATION POLYMORPHISM METHOD [J].
KASHII, T ;
MIZUSHIMA, Y ;
MONNO, S ;
NAKAGAWA, K ;
KOBAYASHI, M .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (03) :143-148
[43]   Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer [J].
Andriani, F. ;
Perego, P. ;
Carenini, N. ;
Sozzi, G. ;
Roz, L. .
NEOPLASIA, 2006, 8 (01) :9-17
[44]   CYTOMORPHOLOGICAL, CYTOGENETIC, AND MOLECULAR BIOLOGICAL CHARACTERIZATION OF 4 NEW HUMAN RENAL-CARCINOMA CELL-LINES OF THE CLEAR-CELL TYPE [J].
GERHARZ, CD ;
RAMP, U ;
OLERT, J ;
MOLL, R ;
STORKEL, S ;
MARX, N ;
GABBERT, HE .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1994, 424 (04) :403-409
[45]   INHIBITION OF PROTEIN-KINASE-C DEPENDENT CELL-PROLIFERATION OF HUMAN LUNG-CANCER CELL-LINES BY THE DIHYDROPYRIDINE DEXNIGULDIPINE [J].
SCHULLER, HM ;
ORLOFF, M ;
REZNIK, GK .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (06) :354-358
[46]   REDUCTION OF CISPLATIN CYTOTOXICITY ON HUMAN LUNG-CANCER CELL-LINES WITH N-MYC AMPLIFICATION BY PRETREATMENT WITH N-MYC ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
MIZUSHIMA, Y ;
KASHII, T ;
KOBAYASHI, M .
ANTICANCER RESEARCH, 1995, 15 (01) :37-43
[47]   In Vitro and in Vivo Antitumor Activity of Scutebarbatine A on Human Lung Carcinoma A549 Cell Lines [J].
Yang, Xiao-Kun ;
Xu, Ming-Yuan ;
Xu, Gui-Sen ;
Zhang, Yu-Lan ;
Xu, Zhao-Xia .
MOLECULES, 2014, 19 (07) :8740-8751
[48]   REACTIVITY OF MONOCLONAL-ANTIBODIES DIRECTED AGAINST LUNG-CANCER ANTIGENS WITH HUMAN LUNG, BREAST AND COLON-CANCER CELL-LINES [J].
SCHUMACHER, U ;
MUKTHAR, D ;
SCHENKER, T .
DISEASE MARKERS, 1993, 11 (5-6) :225-237
[49]   MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma [J].
Ning, Zhi-Qiang ;
Lu, Hai-lin ;
Chen, Chao ;
Wang, Lin ;
Cai, Wei ;
Li, Yan ;
Cao, Ting-hua ;
Zhu, Jing ;
Shu, Yong-Qian ;
Shen, Hua .
ONCOTARGET, 2017, 8 (03) :4572-4581
[50]   Expression of SIRT1 gene in human lung cancer lines enhances their sensitivity to the anticancer effects of cisplatin [J].
Hu, L-Y ;
Hou, Y-B ;
Yu, L-H ;
Mi, Y-H ;
Zhang, J-W ;
Wang, K. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (14) :4551-4556
12345